Veltam Plus Tablet MR

Veltam Plus Tablet MR (Tamsulosin Hydrochloride & Dutasteride)

Veltam Plus Tablet MR is a high-potency pharmacological intervention specifically engineered for the clinical management of moderate-to-severe symptomatic Benign Prostatic Hyperplasia (BPH). Utilizing a unique “Dual-Action” delivery system, this formulation works by concurrently modulating the smooth muscle tension in the urinary passage and reinforcing the reduction of the physical volume of the prostate gland. By combining an alpha-1 adrenoceptor antagonist with a 5-alpha reductase inhibitor, Veltam Plus effectively promotes an immediate increase in urinary flow and facilitates the organized suppression of dihydrotestosterone (DHT) levels. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the prostatic tissues and promoting a stable, physiological recovery from obstructive urological stressors.

Key Features

• Specifically formulated with Tamsulosin and Dutasteride to target both the dynamic and static components of BPH.
• Clinically recognized for its role in facilitating the natural optimization of hormone-driven prostatic growth cycles.
• Specifically engineered to reach therapeutic levels steadily, ensuring a robust defense against nocturnal frequency and urinary urgency.
• Acts as a functional catalyst to stabilize the bladder neck function and support the long-term reduction of prostate volume.
• Formulated to address the risk of acute urinary retention and the potential requirement for urological surgery.

Key Ingredients

• Tamsulosin Hydrochloride (0.4 mg)
• Dutasteride (0.5 mg)
• Microcrystalline Cellulose
• Magnesium Stearate

Precautions

• This is a high-potency urological medication. Use must be strictly dictated by a healthcare professional after a formal clinical diagnosis and PSA screening.
• Patients utilizing this formulation must not donate blood until at least 6 months after the final dose to prevent exposure to pregnant recipients.
• Inform your surgeon of Veltam Plus use prior to cataract or glaucoma procedures to manage the risk of Intraoperative Floppy Iris Syndrome (IFIS).
• Because Dutasteride can be absorbed through the skin, women who are pregnant or may become pregnant must not handle the tablets.
• Be advised that temporary dizziness may occur; exercise caution when transitioning between seated and standing positions.
• Keep the blister pack tightly sealed and store in a cool, dry place (below 25°C). Protect from direct light to maintain the molecular stability of the active constituents.

How to Use

• The tablet should be swallowed whole with a glass of water. Do not crush or chew the tablet to ensure the intended modified-release delivery.
• A single tablet constitutes the standard daily therapeutic dose, unless otherwise specifically directed by a urologist.
• For optimal clinical results, administration should occur approximately 30 minutes following the same meal each day.
• Ensure consistent daily intake to maintain stable plasma concentrations and facilitate the long-term reduction of prostatic volume.
• Use as a standalone urological treatment for advanced BPH as dictated by your clinical restoration regimen.
• Maintain a regular application schedule for a minimum of 3 to 6 months to document visible improvements in urinary flow and glandular reduction.

Legal Disclaimer: Veltam Plus Tablet MR is a specialized pharmacological intervention. Individual results vary based on the patient’s baseline prostatic volume and physiological response. This product is intended for male physiological requirements only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.